NO20025081L - Stabilt flytende preparat - Google Patents

Stabilt flytende preparat

Info

Publication number
NO20025081L
NO20025081L NO20025081A NO20025081A NO20025081L NO 20025081 L NO20025081 L NO 20025081L NO 20025081 A NO20025081 A NO 20025081A NO 20025081 A NO20025081 A NO 20025081A NO 20025081 L NO20025081 L NO 20025081L
Authority
NO
Norway
Prior art keywords
liquid preparation
stable liquid
sitafloxazin
sitafloxacin
aqueous solution
Prior art date
Application number
NO20025081A
Other languages
English (en)
Other versions
NO323810B1 (no
NO20025081D0 (no
Inventor
Masanori Araki
Hiroaki Nakagami
Azusa Matsukawa
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of NO20025081D0 publication Critical patent/NO20025081D0/no
Publication of NO20025081L publication Critical patent/NO20025081L/no
Publication of NO323810B1 publication Critical patent/NO323810B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Et flytende preparat av sitafloksacin som har fremragende lysstabilitet og som består av en vandig oppløsning som inneholder både sitafloksazin og natriumklorid.
NO20025081A 2000-04-24 2002-10-22 Flytende preparat og fremgangsmate for fremstilling derav. NO323810B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000127622 2000-04-24
JP2000149812 2000-05-17
PCT/JP2001/003457 WO2001080858A1 (fr) 2000-04-24 2001-04-23 Preparation liquide stable

Publications (3)

Publication Number Publication Date
NO20025081D0 NO20025081D0 (no) 2002-10-22
NO20025081L true NO20025081L (no) 2002-12-23
NO323810B1 NO323810B1 (no) 2007-07-09

Family

ID=26590975

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025081A NO323810B1 (no) 2000-04-24 2002-10-22 Flytende preparat og fremgangsmate for fremstilling derav.

Country Status (20)

Country Link
US (1) US7304075B2 (no)
EP (1) EP1277471B1 (no)
JP (1) JP5027975B2 (no)
KR (1) KR100858228B1 (no)
CN (1) CN1326524C (no)
AR (1) AR028028A1 (no)
AT (1) ATE396729T1 (no)
AU (1) AU2001248833A1 (no)
BR (1) BR0110290A (no)
CA (1) CA2406849C (no)
DE (1) DE60134221D1 (no)
DK (1) DK1277471T3 (no)
ES (1) ES2305065T3 (no)
HK (1) HK1050326A1 (no)
MX (1) MXPA02010497A (no)
NO (1) NO323810B1 (no)
PT (1) PT1277471E (no)
RU (1) RU2295342C2 (no)
TW (1) TWI280131B (no)
WO (1) WO2001080858A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
ATE528003T1 (de) * 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
JP2006151808A (ja) * 2002-12-24 2006-06-15 Dai Ichi Seiyaku Co Ltd 抗菌性水性製剤
CA2661618A1 (en) 2006-08-25 2008-02-28 Astellas Pharma Inc. Stabilized pharmaceutical composition
JP5258331B2 (ja) * 2008-03-03 2013-08-07 ロート製薬株式会社 光安定性が改善されたニューキノロン系抗菌剤含有医薬組成物
WO2010146478A1 (en) * 2009-05-08 2010-12-23 Ranbaxy Laboratories Limited Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
CN101690712B (zh) * 2009-08-25 2011-06-15 武汉武药科技有限公司 一种西他沙星滴眼剂及其制备方法
CN103087042B (zh) * 2012-03-09 2015-02-18 南京优科生物医药有限公司 西他沙星的盐及制药用途
SG11201408511QA (en) * 2012-06-27 2015-01-29 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103622973B (zh) * 2013-12-02 2016-05-11 广东恒诚制药有限公司 一种复方醋酸曲安奈德溶液的制备方法
AT524927A1 (de) * 2021-04-07 2022-10-15 Engel Austria Gmbh Plastifiziereinheit für eine Formgebungsmaschine und Verfahren zum Betreiben einer solchen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL90062A (en) * 1988-04-27 1994-10-07 Daiichi Seiyaku Co History of pyridonecarboxylic acid, their preparation and pharmaceutical preparations containing them
RU2044544C1 (ru) 1989-04-28 1995-09-27 Дайити Фармасьютикал Ко., Лтд Композиция против вируса иммунодефицита человека
CA2053926A1 (en) 1989-04-28 1990-10-29 Genkichi Ohta Anti-hiv agent

Also Published As

Publication number Publication date
US7304075B2 (en) 2007-12-04
KR20020089523A (ko) 2002-11-29
RU2295342C2 (ru) 2007-03-20
HK1050326A1 (en) 2003-06-20
EP1277471A4 (en) 2006-04-12
MXPA02010497A (es) 2003-05-14
DK1277471T3 (da) 2008-08-11
AR028028A1 (es) 2003-04-23
BR0110290A (pt) 2003-02-18
EP1277471B1 (en) 2008-05-28
US20030139436A1 (en) 2003-07-24
KR100858228B1 (ko) 2008-09-12
JP5027975B2 (ja) 2012-09-19
DE60134221D1 (de) 2008-07-10
NO323810B1 (no) 2007-07-09
ES2305065T3 (es) 2008-11-01
CA2406849C (en) 2007-10-23
PT1277471E (pt) 2008-08-26
CN1326524C (zh) 2007-07-18
TWI280131B (en) 2007-05-01
NO20025081D0 (no) 2002-10-22
CA2406849A1 (en) 2002-10-21
CN1438888A (zh) 2003-08-27
WO2001080858A1 (fr) 2001-11-01
AU2001248833A1 (en) 2001-11-07
RU2002128631A (ru) 2004-03-27
ATE396729T1 (de) 2008-06-15
EP1277471A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
NO20025081L (no) Stabilt flytende preparat
NO20024891L (no) Farmasöytiske sammensetninger
DK1276738T3 (da) 2-amino-3- (alkyl) - pyrimidinderivater som GSK3-betainhibitorer
CY2012023I2 (el) ΔΙΑΛΥΤΟΤΗΤΑ ΙFΝ-ΒΗΤΑ-1b ΣΕ ΔΙΑΛΥΜΑΤΑ ΧΛΩΡΙΟΥΧΟΥΝΑΤΡΙΟΥ
DK1330452T3 (da) Pyrazinderivater som modulatorer af tyrosinkinaser
SV2004001225A (es) Derivados de sulfonamida ref.rck 00014-sv
EE04930B1 (et) K?rgkontsentreeritud stabiilsed meloksikaami lahused
NO20032388L (no) Salter av et isotiazol-4-karboksamid og anvendelse derav som anti-hyperproliferasjonsmidler
CY1105411T1 (el) Νεα παραγωγα πλευρομουτιλινης
IS6954A (is) Notkun á enantíómerískt hreinu essítalóprami
MXPA04004864A (es) Composiciones herbicidas que comprenden benzoil-pirazoles y aditivos protectores.
DE50213681D1 (de) Wässrige Lösung von Ascorbinsäure
EE200400023A (et) Uued sulfoonhappe derivaadid
DK1377579T3 (da) Acyl- og sulfonylderivater af 6,9-disubstitueret-2(trans-1,4-diaminocyklohexyl)puriner og deres anvendelse som antiproliferative midler
EE05549B1 (et) L„mmastikku sisaldavate snergistidega kloraati sisaldav stabilisaatorssteem halogeeni sisaldavate polmeeride stabiliseerimiseks
DE60215685D1 (de) Stabilisierte hydroxylaminlösungen
UY27461A1 (es) Formas pseudopolimorficas de cardevilol.
NO20030998D0 (no) Arylpiperazinderivater og deres anvendelse som psykotropiske midler
DE60132511D1 (de) E-isomeren von fullerenderivate
PT1194145E (pt) Solucao estavel de xilometazolina e de oximetazolina
NO20055882L (no) Farmasoytiske formuleringer omfattende amoksicillin og klavulanat
DE60232018D1 (de) 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha
DE60136064D1 (de) Wässrige flüssige preparation von pranoprofen
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
UY26854A1 (es) Agente terapéutico cristalino

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees